{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:25Z","timestamp":1794017245734,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To investigate the clinicopathological characteristics, diagnoses, treatments, and outcomes of a special type of gestational trophoblastic neoplasia (GTN) which only has extrauterine metastases without uterine primary lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The medical records and pathological sections of the patients who were pathologically diagnosed as GTN, only had extrauterine metastatic lesions but lacked uterine primary lesions, in Women\u2019s Hospital of Zhejiang University School of Medicine from February 2014 to March 2021 were collected and reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen patients with pathologically confirmed GTN presenting with extrauterine metastases from a missing primary site were included in the past 7\u00a0years. The median age was 31.2\u00a0years old. 76.9% of patients had a non-hydatidiform pregnancy last time. The intervals between the antecedent pregnancy were\u2009&gt;\u200912\u00a0months in 61.5% of patients. Pretreatment serum human chorionic gonadotropin(hCG) levels ranged from 118.7 to 807,270\u00a0IU\/L. Six patients were misdiagnosed as ectopic pregnancy at initial diagnosis, and 4 as primary tumors at metastatic sites. All of them were diagnosed definitely by surgical pathology including 8 choriocarcinomas (CC), 4 epithelioid trophoblastic tumors (ETTs), and 1 mixed GTN (CC mixed with ETT). All patients achieved complete remission (CR) after treatments. Three patients relapsed; no patient died by the end of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>GTN presenting with extrauterine metastases from a missing primary site is easily misdiagnosed. Detection of serum hCG in these patients can reduce misdiagnosis. Chemotherapy combined with individualized surgery should be considered for these special GTN patients. Immune checkpoint inhibitors might be potential remedial measures for refractory and recurrent patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-09620-2","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T12:17:48Z","timestamp":1651839468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: a single center experience and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Jingnan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"issue":"9742","key":"9620_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","volume":"376","author":"MJ Seckl","year":"2010","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717\u201329. https:\/\/doi.org\/10.1016\/S0140-6736(10)60280-2 Epub 2010 Jul 29 PMID: 20673583.","journal-title":"Lancet"},{"issue":"6","key":"9620_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","volume":"203","author":"JR Lurain","year":"2010","unstructured":"Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.073 Epub 2010 Aug 21.","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"9620_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijgo.12615","volume":"143","author":"HYS Ngan","year":"2018","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018;143(Suppl 2):79\u201385. https:\/\/doi.org\/10.1002\/ijgo.12615.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"9620_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","volume":"112","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009;112(3):654\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.005.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"9620_CR5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.7504\/fk201611015","volume":"32","author":"XY Jiang Fang","year":"2016","unstructured":"Jiang Fang XY, Wan X, et al. Evaluation of the FIGO 2000 staging and risk factor scoring system for gestational trophoblastic neoplasia. Chin J Pract Gynecol Obstet. 2016;32(12):1198\u2013203. https:\/\/doi.org\/10.7504\/fk201611015.","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"20","key":"9620_CR6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053 PMID: 24141714.","journal-title":"JAMA"},{"key":"9620_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.humpath.2018.10.001","volume":"84","author":"B Lu","year":"2019","unstructured":"Lu B, Teng X, Fu G, Bao L, Tang J, Shi H, Lu W, Lu Y. Analysis of PD-L1 expression in trophoblastic tissues and tumors. Hum Pathol. 2019;84:202\u201312. https:\/\/doi.org\/10.1016\/j.humpath.2018.10.001 Epub 2018 Oct 17.","journal-title":"Hum Pathol"},{"key":"9620_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2021.11.004","volume":"161","author":"F Jiang","year":"2022","unstructured":"Jiang F, Lin JK, Xiang Y, Xu ZF, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study. Eur J Cancer. 2022;161:119\u201327. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.004 Epub 2021 Dec 13 PMID: 34911640.","journal-title":"Eur J Cancer"},{"key":"9620_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bpobgyn.2021.01.005","volume":"74","author":"A Braga","year":"2021","unstructured":"Braga A, Elias KM, Horowitz NS, Berkowitz RS. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance\/relapsed disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:81\u201396. https:\/\/doi.org\/10.1016\/j.bpobgyn.2021.01.005 Epub 2021 Feb 2 PMID: 33622563.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9","key":"9620_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fonc.2019.01262.PMID:31803628;PMCID:PMC6873612","volume":"15","author":"Y Kong","year":"2019","unstructured":"Kong Y, Tao G, Zong L, Yang J, Wan X, Wang W, Xiang Y. Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature. Front Oncol. 2019;15(9):1262. https:\/\/doi.org\/10.3389\/fonc.2019.01262.PMID:31803628;PMCID:PMC6873612.","journal-title":"Front Oncol"},{"issue":"11","key":"9620_CR11","first-page":"804","volume":"45","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Feng FZ, Xiang Y, Wan XR. Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi. 2010;45(11):804\u20137 Chinese PMID: 21211275.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"16","key":"9620_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010306","volume":"97","author":"W Lei","year":"2018","unstructured":"Lei W, Zhang F, Zheng C, Zhao C, Tu S, Bao Y. Metastatic epithelioid trophoblastic tumor of the lung: A case report. Medicine (Baltimore). 2018;97(16): e0306. https:\/\/doi.org\/10.1097\/MD.0000000000010306.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"9620_CR13","first-page":"22041","volume":"9","author":"HS Ru Luo","year":"2016","unstructured":"Ru Luo HS, Chen X, L\u00fc B, Shao H. Extrauterine epithelioid trophoblastic tumor of the vagina: a case report and literature review. Int J Clin Exp Med. 2016;9(11):22041\u20137.","journal-title":"Int J Clin Exp Med"},{"key":"9620_CR14","doi-asserted-by":"publisher","unstructured":"Chohan MO, Rehman T, Cerilli LA, Devers K, Medina-Flores R, Turner P. Metastatic epithelioid trophoblastic tumor involving the spine. Spine (Phila Pa 1976). 2010 Sep 15;35(20): E1072\u20135. doi: https:\/\/doi.org\/10.1097\/BRS.0b013e3181d7696b.","DOI":"10.1097\/BRS.0b013e3181d7696b"},{"issue":"3","key":"9620_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1447-0756.2007.00545.x","volume":"33","author":"S Urabe","year":"2007","unstructured":"Urabe S, Fujiwara H, Miyoshi H, Arihiro K, Soma H, Yoshihama I, Mineo S, Kudo Y. Epithelioid trophoblastic tumor of the lung. J Obstet Gynaecol Res. 2007;33(3):397\u2013401. https:\/\/doi.org\/10.1111\/j.1447-0756.2007.00545.x.","journal-title":"J Obstet Gynaecol Res"},{"issue":"11","key":"9620_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/s0046-8177(99)90063-1","volume":"30","author":"S Hamazaki","year":"1999","unstructured":"Hamazaki S, Nakamoto S, Okino T, Tsukayama C, Mori M, Taguchi K, Okada S. Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol. 1999;30(11):1321\u20137. https:\/\/doi.org\/10.1016\/s0046-8177(99)90063-1.","journal-title":"Hum Pathol"},{"issue":"37","key":"9620_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100819","volume":"23","author":"SG Bell","year":"2021","unstructured":"Bell SG, Uppal S, Sakala MD, Sciallis AP, Rolston A. An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab. Gynecol Oncol Rep. 2021;23(37): 100819. https:\/\/doi.org\/10.1016\/j.gore.2021.100819.","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"9620_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2015.03.006","volume":"137","author":"MR Davis","year":"2015","unstructured":"Davis MR, Howitt BE, Quade BJ, Crum CP, Horowitz NS, Goldstein DP, Berkowitz RS. Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center. Gynecol Oncol. 2015;137(3):456\u201361. https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.006 Epub 2015 Mar 12.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"9620_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.5858\/arpa.2019-0207-OA","volume":"144","author":"RD Whaley","year":"2020","unstructured":"Whaley RD, Dougherty RE, Cheng L, Ulbright TM. Fluorescence In Situ Hybridization for the X and Y Chromosome Centromeres Helps Differentiate Between Gestational and Nongestational Choriocarcinoma in Clinically Ambiguous Cases. Arch Pathol Lab Med. 2020;144(7):863\u20138. https:\/\/doi.org\/10.5858\/arpa.2019-0207-OA.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"9620_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12149-012-0644-x","volume":"26","author":"Y Maruoka","year":"2012","unstructured":"Maruoka Y, Abe K, Baba S, Isoda T, Matsuo Y, Kubo Y, Ogawa S, Yano T, Sasaki M, Honda H. A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology. Ann Nucl Med. 2012;26(10):835\u20139. https:\/\/doi.org\/10.1007\/s12149-012-0644-x Epub 2012 Aug 15.","journal-title":"Ann Nucl Med"},{"key":"9620_CR21","doi-asserted-by":"publisher","unstructured":"Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C; ESMO Guidelines Working Group. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24 Suppl 6:vi39\u201350. doi: https:\/\/doi.org\/10.1093\/annonc\/mdt345. Epub 2013 Sep 1.","DOI":"10.1093\/annonc\/mdt345"},{"issue":"7","key":"9620_CR22","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/cam4.2901","volume":"9","author":"Y Kong","year":"2020","unstructured":"Kong Y, Zong L, Cheng H, Jiang F, Wan X, Feng F, Ren T, Zhao J, Yang J, Xiang Y. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017. Cancer Med. 2020;9(7):2590\u20139. https:\/\/doi.org\/10.1002\/cam4.2901 Epub 2020 Feb 5.","journal-title":"Cancer Med"},{"issue":"3","key":"9620_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ygyno.2004.11.011","volume":"96","author":"H Matsui","year":"2005","unstructured":"Matsui H, Suzuka K, Yamazawa K, Tanaka N, Mitsuhashi A, Seki K, Sekiya S. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol. 2005;96(3):616\u201320. https:\/\/doi.org\/10.1016\/j.ygyno.2004.11.011.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"9620_CR24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/bjc.2012.462","volume":"107","author":"A Sita-Lumsden","year":"2012","unstructured":"Sita-Lumsden A, Short D, Lindsay I, Sebire NJ, Adjogatse D, Seckl MJ, Savage PM. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000\u20132009. Br J Cancer. 2012;107(11):1810\u20134. https:\/\/doi.org\/10.1038\/bjc.2012.462 (Epub 2012 Oct 11).","journal-title":"Br J Cancer"},{"issue":"3","key":"9620_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/IGC.0000000000000892","volume":"27","author":"PA Bolze","year":"2017","unstructured":"Bolze PA, Patrier S, Massardier J, Hajri T, Abbas F, Schott AM, Allias F, Devouassoux-Shisheboran M, Freyer G, Golfier F, You B. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes. Int J Gynecol Cancer. 2017;27(3):554\u201361. https:\/\/doi.org\/10.1097\/IGC.0000000000000892.","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Pt 1","key":"9620_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","volume":"112","author":"AV Hoekstra","year":"2008","unstructured":"Hoekstra AV, Lurain JR, Rademaker AW, Schink JC. Gestational trophoblastic neoplasia: treatment outcomes. Obstet Gynecol. 2008;112(2 Pt 1):251\u20138. https:\/\/doi.org\/10.1097\/AOG.0b013e31817f58ae PMID: 18669719.","journal-title":"Obstet Gynecol"},{"key":"9620_CR27","doi-asserted-by":"publisher","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374\u20131391. doi: https:\/\/doi.org\/10.6004\/jnccn.2019.0053.","DOI":"10.6004\/jnccn.2019.0053"},{"issue":"10110","key":"9620_CR28","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","volume":"390","author":"E Ghorani","year":"2017","unstructured":"Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, Akarca A, Marafioti T, Quezada SA, Sarwar N, Seckl MJ. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 2017;390(10110):2343\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(17)32894-5.","journal-title":"Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09620-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T12:21:42Z","timestamp":1651839702000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9620"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09620-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"assertion":[{"value":"26 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Women's Hospital of Zhejiang University School of Medicine. Informed consents were obtained before data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"509"}}